Tapewire

Nasdaq · USD

VREX

Varex Imaging Corp

Export transactions ↓
Tapewire entity
5135
SEC CIK
0001681622
Parsed reports
278

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 09, 2022 Filed Dec 13, 2022 18:15 UTC
SANYAL SUNNYDirector · President and CEO
GrantNon-Qualified Stock Option (right to buy) · Derivative 167,353 $0.00 Strike: $22.13 $0.00
Disclosure

SEC source: 0001681622-22-000098 · wf-form4_167097333215461.xml · derivative · entry 1

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 167,353

Underlying: Common Stock · 167,353 shares

Expires 2032-12-09

F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest on December 10, 2023, and the remaining options vest monthly thereafter on the 10th day of each month on a pro rata basis.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 18:17 UTC
Maheshwari ShubhamChief Financial Officer
GrantRestricted Stock Units · Derivative 19,756 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000100 · wf-form4_167097338710016.xml · derivative · entry 2

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,756

Underlying: Common Stock · 19,756 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date.

F3 · derivative.expiration_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 18:17 UTC
Maheshwari ShubhamChief Financial Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 40,937 $0.00 Strike: $22.13 $0.00
Disclosure

SEC source: 0001681622-22-000100 · wf-form4_167097338710016.xml · derivative · entry 1

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,937

Underlying: Common Stock · 40,937 shares

Expires 2032-12-09

F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest on December 10, 2023, and the remaining options vest monthly thereafter on the 10th day of each month on a pro rata basis.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 23:15 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
GrantRestricted Stock Units · Derivative 13,046 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000097 · wf-form4_167097331413632.xml · derivative · entry 2

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,046

Underlying: Common Stock · 13,046 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date.

F3 · derivative.expiration_date: These Restricted Stock Units granted on December 9, 2022 vest 50% on December 10, 2024 and 50% on December 10, 2026. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 23:15 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
GrantNon-Qualified Stock Option (right to buy) · Derivative 27,033 $0.00 Strike: $22.13 $0.00
Disclosure

SEC source: 0001681622-22-000097 · wf-form4_167097331413632.xml · derivative · entry 1

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,033

Underlying: Common Stock · 27,033 shares

Expires 2032-12-09

F1 · derivative.exercise_date: These Performance Stock Options are subject to a four-year vesting schedule. 25% of the total number of options vest on December 10, 2023, and the remaining options vest monthly thereafter on the 10th day of each month on a pro rata basis.

Read SEC document
August 24, 2022 Filed Nov 9, 2022 19:00 UTC SaleCommon Stock 5,000 $21.60 $108,000.00
Disclosure

SEC source: 0001681622-22-000083 · wf-form4_166803838636960.xml · nonDerivative · entry 1

NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,375

F1 · date: This Form 4 is being filed late due to an inadvertent administrative error.

F2 · price: All individual shares were sold at a price of $21.60

Read SEC document
August 18, 2022 Filed Aug 22, 2022 17:05 UTC
Honeysett Kimberley E.SVP and General Counsel
SaleCommon Stock 3,028 $23.50 $71,158.00
Disclosure

SEC source: 0001681622-22-000081 · wf-form4_166120232904706.xml · nonDerivative · entry 1

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,733

F1 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 31, 2022. All shares were sold at $23.50

F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 218 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

Read SEC document
August 18, 2022 Filed Aug 22, 2022 17:05 UTC GrantDeferred Stock Units · Derivative 3,619 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000080 · wf-form4_166120230561881.xml · derivative · entry 1

Bardwell Kathleen · CIK 0001532367 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,619

Underlying: Common Stock · 3,619 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F2 · derivative.exercise_date: These Deferred Stock Units vest in full on the date of the next annual meeting (February 9, 2023) subject to the reporting person serving on the board of the company through the vesting date. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 annual meeting (ii) a change in control, (iii) the non-employee director termination of service for any reason.

F2 · derivative.expiration_date: These Deferred Stock Units vest in full on the date of the next annual meeting (February 9, 2023) subject to the reporting person serving on the board of the company through the vesting date. Vested shares will be delivered to the reporting person upon the earlier of (i) 2025 annual meeting (ii) a change in control, (iii) the non-employee director termination of service for any reason.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 18:57 UTC
Maheshwari ShubhamChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 30,315 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000074 · wf-form4_166069063878185.xml · derivative · entry 3

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,315

Underlying: Common Stock · 30,315 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The Restricted Stock Units granted on October 2, 2020 vest 50% on August 15, 2022 and 50% on August 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: The Restricted Stock Units granted on October 2, 2020 vest 50% on August 15, 2022 and 50% on August 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 18:57 UTC
Maheshwari ShubhamChief Financial Officer
Tax withholdingCommon Stock 7,640 $22.31 $170,448.40
Disclosure

SEC source: 0001681622-22-000074 · wf-form4_166069063878185.xml · nonDerivative · entry 2

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,540

F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 18:57 UTC
Maheshwari ShubhamChief Financial Officer
Exercise / conversionCommon Stock 30,315 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000074 · wf-form4_166069063878185.xml · nonDerivative · entry 1

Maheshwari Shubham · CIK 0001607969 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,180

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 3,865 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 22:57 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
Exercise / conversionRestricted Stock Units · Derivative 1,638 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · derivative · entry 3

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,638 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F3 · derivative.expiration_date: The Restricted Stock Units granted on August 24, 2018 vest 25% each year for four years beginning on August 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 22:57 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
Tax withholdingCommon Stock 724 $22.31 $16,152.44
Disclosure

SEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · nonDerivative · entry 2

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,059

F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 22:57 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
Exercise / conversionCommon Stock 1,638 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000073 · wf-form4_166069061117432.xml · nonDerivative · entry 1

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,783

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
June 06, 2022 Filed Jun 8, 2022 17:30 UTC SaleCommon Stock 5,207 $22.62 $117,782.34
Disclosure

SEC source: 0001681622-22-000056 · wf-form4_165472378253949.xml · nonDerivative · entry 1

NAUMANN-ETIENNE RUEDIGER · CIK 0001219636 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,375

F1 · price: All individual shares were sold at a price of $22.62

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:05 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
Exercise / conversionRestricted Stock Units · Derivative 5,134 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · derivative · entry 7

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,135

Underlying: Common Stock · 5,134 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:05 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
Exercise / conversionRestricted Stock Units · Derivative 1,420 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · derivative · entry 6

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,420

Underlying: Common Stock · 1,420 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:05 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
Exercise / conversionRestricted Stock Units · Derivative 1,203 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · derivative · entry 5

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,203 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:05 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
Tax withholdingCommon Stock 2,946 $23.47 $69,142.62
Disclosure

SEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · nonDerivative · entry 4

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,922

F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:05 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
Exercise / conversionCommon Stock 5,134 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · nonDerivative · entry 3

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,868

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:05 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
Exercise / conversionCommon Stock 1,420 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · nonDerivative · entry 2

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,734

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:05 UTC
Giambattista Brian WSVP and GM, X-ray Detectors
Exercise / conversionCommon Stock 1,203 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000041 · wf-form4_164513549620963.xml · nonDerivative · entry 1

Giambattista Brian W · CIK 0001705559 · SVP and GM, X-ray Detectors

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,314

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:03 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionRestricted Stock Units · Derivative 5,086 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · derivative · entry 8

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,086

Underlying: Common Stock · 5,086 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F6 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

F6 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:03 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionRestricted Stock Units · Derivative 1,397 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · derivative · entry 7

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,397

Underlying: Common Stock · 1,397 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:03 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionRestricted Stock Units · Derivative 1,104 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · derivative · entry 6

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,104 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:03 UTC
Honeysett Kimberley E.SVP and General Counsel
Tax withholdingCommon Stock 3,578 $23.47 $83,975.66
Disclosure

SEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · nonDerivative · entry 4

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,543

F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:03 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionCommon Stock 5,086 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · nonDerivative · entry 3

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,121

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:03 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionCommon Stock 1,397 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · nonDerivative · entry 2

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:03 UTC
Honeysett Kimberley E.SVP and General Counsel
Exercise / conversionCommon Stock 1,104 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000038 · wf-form4_164513540065444.xml · nonDerivative · entry 1

Honeysett Kimberley E. · CIK 0001695094 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,638

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 171 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionRestricted Stock Units · Derivative 4,890 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · derivative · entry 7

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,890

Underlying: Common Stock · 4,890 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F6 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

F6 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionRestricted Stock Units · Derivative 1,354 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · derivative · entry 6

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,354

Underlying: Common Stock · 1,354 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionRestricted Stock Units · Derivative 1,147 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · derivative · entry 5

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,147 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Tax withholdingCommon Stock 3,488 $23.47 $81,863.36
Disclosure

SEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · nonDerivative · entry 4

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,463

F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 4,890 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · nonDerivative · entry 3

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,951

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 1,354 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · nonDerivative · entry 2

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,061

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
Jonaitis Mark S.SVP and GM, X-Ray Sources
Exercise / conversionCommon Stock 1,147 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000039 · wf-form4_164513542789734.xml · nonDerivative · entry 1

Jonaitis Mark S. · CIK 0001695264 · SVP and GM, X-Ray Sources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,707

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 2,185 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
SANYAL SUNNYDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 30,223 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · derivative · entry 7

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,223

Underlying: Common Stock · 30,223 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F5 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

F5 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
SANYAL SUNNYDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 8,374 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · derivative · entry 6

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,374

Underlying: Common Stock · 8,374 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
SANYAL SUNNYDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 7,092 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · derivative · entry 5

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,092 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
SANYAL SUNNYDirector · President and CEO
Tax withholdingCommon Stock 20,363 $23.47 $477,919.61
Disclosure

SEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · nonDerivative · entry 4

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,952

F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
SANYAL SUNNYDirector · President and CEO
Exercise / conversionCommon Stock 30,223 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · nonDerivative · entry 3

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
SANYAL SUNNYDirector · President and CEO
Exercise / conversionCommon Stock 8,374 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · nonDerivative · entry 2

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,092

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 17:04 UTC
SANYAL SUNNYDirector · President and CEO
Exercise / conversionCommon Stock 7,092 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000040 · wf-form4_164513545334263.xml · nonDerivative · entry 1

SANYAL SUNNY · CIK 0001599398 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,718

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 22:06 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
Exercise / conversionRestricted Stock Units · Derivative 5,134 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · derivative · entry 5

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,135

Underlying: Common Stock · 5,134 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F4 · derivative.exercise_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

F4 · derivative.expiration_date: The Restricted Stock Units granted on February 18, 2020 vest 50% on February 15, 2022 and 50% on February 15, 2024. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 22:06 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
Exercise / conversionRestricted Stock Units · Derivative 1,623 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · derivative · entry 4

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,623

Underlying: Common Stock · 1,623 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

F3 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 22:06 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
Tax withholdingCommon Stock 3,206 $23.47 $75,244.82
Disclosure

SEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 3

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,145

F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 22:06 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
Exercise / conversionCommon Stock 5,134 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 2

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,351

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 15, 2022 Filed Feb 17, 2022 22:06 UTC
Hartmann AndrewSVP Sales & Marketing, Medical
Exercise / conversionCommon Stock 1,623 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000042 · wf-form4_164513555572277.xml · nonDerivative · entry 1

Hartmann Andrew · CIK 0001846805 · SVP Sales & Marketing, Medical

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,217

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

Read SEC document
February 14, 2022 Filed Feb 15, 2022 00:16 UTC Exercise / conversionDeferred Stock Units · Derivative 5,098 $0.00 $0.00
Disclosure

SEC source: 0001681622-22-000022 · wf-form4_164488415846600.xml · derivative · entry 3

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,098 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

F3 · derivative.exercise_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022.

F3 · derivative.expiration_date: These Deferred Stock Units vested on February 14, 2020. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 14, 2022.

Read SEC document
February 14, 2022 Filed Feb 15, 2022 00:16 UTC Exercise / conversionCommon Stock 5,098 Not disclosed Not disclosed
Disclosure

SEC source: 0001681622-22-000022 · wf-form4_164488415846600.xml · nonDerivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.